Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067678 · ClinicalTrials.gov registry record · Phase 1
Soy Protein in Early Diabetic Nephropathy
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00067678 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00067678, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Diabetic nephropathy is a frequent cause of end-stage renal disease. Reduction of dietary protein has been used to slow down renal disease progression, but patients are often unwilling to make these dietary changes. Other research suggests that changing the quality of dietary protein may be as effective as reducing the total amount of ingested protein. This study hopes to show that soy protein, a plant protein relatively high in essential amino acids and with high nutritional value, maye be beneficial to Type I diabetic patients with incipient renal disease.
Interventions
- DRUG soy protein
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-07 |
| Est. Completion | 2003-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067678
The ClinicalTrials.gov registry entry for NCT00067678 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which soy protein is the first listed.
NCT00067678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067678 about?
NCT00067678 is a clinical study titled "Soy Protein in Early Diabetic Nephropathy". Diabetic nephropathy is a frequent cause of end-stage renal disease. Reduction of dietary protein has been used to slow down renal disease progression, but patients are often unwilling to make these dietary changes. Other research suggests that changing the quality of dietary protein may be as effec...
What is the current status of trial NCT00067678?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-07. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00067678?
The interventions under investigation include: soy protein (DRUG).
Who is sponsoring clinical trial NCT00067678?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.